STAAR Surgical (STAA) Financials

$22.66

$-0.76 (-3.25%)

As on 11-Sep-2026 16:00EDT

Market cap

$1,182 Mln

Revenue (TTM)

$340 Mln

P/E Ratio

294.7

P/B Ratio

3.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Jan-24	Dec-23	Jan-23	Dec-22	Jan-22	Dec-21	Jan-21	Dec-20
Operating Revenue	339.59	239.44	313.90	322.42	322.42	284.39
Cost of Revenue	80.72	57.02	74.32	69.76	69.76	61.01
Gross Profit	258.87	182.42	239.58	252.65	252.65	223.38
Operating Expenses	223.81	228.37	252.19	224.55	224.55	179.58
Operating Profit (EBIT)	35.06	-45.95	-12.61	28.10	28.10	43.80
Other Income	--	--	--	--	--	--
Profit before Tax	17.38	-82.26	-9.05	33.70	33.70	45.80
Provision for Tax	13.54	-1.82	11.16	12.35	12.35	6.80
Profit after Tax (Net Income)	3.84	-80.45	-20.21	21.35	21.35	39.67
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	38.76

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Jan-24	Dec-23	Jan-23	Dec-22	Jan-22	Dec-21	Jan-21	Dec-20
Shareholder's Funds	365.40	344.18	397.34	385.95	385.95	332.44
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	36.41	48.93	41.88	37.70	37.70	30.99
Current Liabilities	73.39	68.50	70.31	65.04	65.04	51.72
Total Liabilities	548.60	461.62	509.52	488.69	488.69	415.15

Assets ($ Mln)	TTM	Dec-25	Dec-24	Jan-24	Dec-23	Jan-23	Dec-22	Jan-22	Dec-21	Jan-21	Dec-20
Non-Current Assets	132.85	150.07	141.58	123.42	123.42	103.18
Current Assets	342.35	311.55	367.94	365.27	365.27	311.97
Total Assets	817.56	461.62	509.52	488.69	488.69	415.15
Total Debt*	35.94	38.35	38.74	35.83	35.83	31.04
Net Current Assets	--	243.04	297.63	300.23	300.23	260.26

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Jan-24	Dec-23	Jan-23	Dec-22	Jan-22	Dec-21	Jan-21	Dec-20
Cash From Operating Activities	--	-34.23	15.73	14.59	14.59	35.72
Cash Flow from Investing Activities	--	46.34	-59.22	--	74.35	-156.38
Cash from Financing Activities	--	-4.56	5.72	7.42	7.42	8.30
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Jan-24	Dec-23	Jan-23	Dec-22	Jan-22	Dec-21	Jan-21	Dec-20
Adjusted EPS ($)	0.07	-1.62	-0.41	--	0.43	--
Cash EPS ($)	--	-1.45	-0.27	--	0.54	--
Adjusted Book Value ($)	--	6.94	8.07	--	7.84	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.69	0.32	--	0.30	--
Free Cash Flow per Share ($)	--	-0.81	-0.16	--	-0.07	--

Profitability Ratios	TTM	Dec-25	Dec-24	Jan-24	Dec-23	Jan-23	Dec-22	Jan-22	Dec-21	Jan-21	Dec-20
ROCE (%)	--	-19.65	-4.71	5.44	5.44	12.13
ROE (%)	1.08	-21.70	-5.16	5.94	5.94	13.42
ROA (%)	0.58	-16.57	-4.05	4.72	4.72	10.43
EBIT Margin (%)	6.78	-34.36	-2.88	8.71	10.45	15.40
Net Margin (%)	1.13	-33.60	-6.44	6.62	6.62	13.95
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Jan-24	Dec-23	Jan-23	Dec-22	Jan-22	Dec-21	Jan-21	Dec-20
Revenue Growth (%)	51.30	-0.24	-0.03	0.13	0.13	0.23
EBIT Growth (%)	130.06	-808.78	-126.86	-35.85	-26.03	31.38
Net Profit Growth (%)	104.03	-298.10	-194.66	-46.18	-46.18	44.18
EPS Growth (%)	103.56	-2.96	-1.95	--	-0.46	--
Book Value Growth (%)	4.39	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Jan-24	Dec-23	Jan-23	Dec-22	Jan-22	Dec-21	Jan-21	Dec-20
Price / Earnings	294.69	-14.23	-59.22	--	71.99	--
Price / Book Value	3.17	3.33	3.01	--	3.98	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	19.98	-13.54	-465.03	-5.57	34.83	-3.61
Close Price ($)	28.69	23.09	24.29	28.01	31.21	70.55
High Price ($)	35.87	30.81	52.68	81.81	81.81	112.27
Low Price ($)	15.59	13.50	23.55	27.00	30.29	46.36
Market Cap ($ Cr)	1,182.14	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Jan-24	Dec-23	Jan-23	Dec-22	Jan-22	Dec-21	Jan-21	Dec-20
Debt to Equity	--	0.11	0.10	0.09	0.09	0.09
Short term debt to equity ratio	0.02	0.02	0.01	0.01	0.01	0.01
Current Ratio	4.66	4.55	5.23	5.62	5.62	6.03
Quick Ratio	4.03	3.74	4.62	5.08	5.08	5.57
Interest Coverage	--	--	--	--	--	17.89

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Jan-24	Dec-23	Jan-23	Dec-22	Jan-22	Dec-21	Jan-21	Dec-20
Debtors to sales (%)	30.05	22.81	25.25	30.39	30.39	21.96
Asset Turnover	0.52	0.49	0.63	0.71	0.71	0.75
Receivable days	--	102.10	103.12	90.87	90.87	68.06
Inventory Days	--	316.43	192.74	155.21	155.21	124.03
Payable days	--	90.57	74.36	65.79	65.79	60.69
Cash Conversion Cycle	--	327.97	221.50	180.29	180.29	131.40

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.